PMC:6723065 / 56068-56583 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6723065","sourcedb":"PMC","sourceid":"6723065","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6723065","text":"Speech therapy has been proposed as a non-pharmacological treatment for parkinsonian hypophonia and dysarthria. Although a degree of improvement is commonly observed with this therapy, a Cochrane review found the scientific evidence to be still inconclusive and postulated the need for a large, well-designed, RCT [221]. Afterwards, a more recent review pointed out the efficacy of Lee Silverman Voice Treatment (LSVT) LOUD for speech disturbances and, remarkably, also in swallowing and in facial expression [222].","tracks":[{"project":"2_test","denotations":[{"id":"31434341-11406044-7278435","span":{"begin":315,"end":318},"obj":"11406044"},{"id":"31434341-25943966-7278436","span":{"begin":510,"end":513},"obj":"25943966"}],"attributes":[{"subj":"31434341-11406044-7278435","pred":"source","obj":"2_test"},{"subj":"31434341-25943966-7278436","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#eccb93","default":true}]}]}}